| Mrs Heather Marie Mclean, NP | |
|
2095 Exchange St Ste 301, Astoria, OR 97103-3400 | |
| (503) 338-4087 | |
| (503) 338-4091 |
| Full Name | Mrs Heather Marie Mclean |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 16 Years |
| Location | 2095 Exchange St Ste 301, Astoria, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932392107 | NPI | - | NPPES |
| 500601876 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 089003393RN (Oregon) | Secondary |
| 363L00000X | Nurse Practitioner | 200850106NP-PP (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Columbia Memorial Hospital | Astoria, OR | Hospital |
| Ocean Beach Hospital | Ilwaco, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbia Lutheran Charities | 5294643359 | 78 |
News Archive
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Using wireless technology may speed patients' postoperative recovery following heart surgery and improve post-discharge outcomes, according to a study in the September 2013 issue of The Annals of Thoracic Surgery.
Researchers at Kanazawa University report in Nature Communications the mechanism making some lung-cancer patients resistant to the drug osimertinib.
According to the American Counsel on Exercise only five percent of dieters are successful in keeping off the weight they lost. In fact, one-third of the weight people initially lost is usually gained back within the first year. People who want to lose weight and keep it off have to not only change their ways, but their way of thinking about food, exercise and lifestyle behaviors.
A team of scholars of Samara National Research University and Samara State Medical University as well as clinic specialists of Samara Regional Oncology Centre tested a new way of skin cancer early diagnostics with the help of original complex of three devices.
› Verified 9 days ago
| Entity Name | Columbia Lutheran Charities |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1134146939 PECOS PAC ID: 5294643359 Enrollment ID: O20021217000028 |
News Archive
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Using wireless technology may speed patients' postoperative recovery following heart surgery and improve post-discharge outcomes, according to a study in the September 2013 issue of The Annals of Thoracic Surgery.
Researchers at Kanazawa University report in Nature Communications the mechanism making some lung-cancer patients resistant to the drug osimertinib.
According to the American Counsel on Exercise only five percent of dieters are successful in keeping off the weight they lost. In fact, one-third of the weight people initially lost is usually gained back within the first year. People who want to lose weight and keep it off have to not only change their ways, but their way of thinking about food, exercise and lifestyle behaviors.
A team of scholars of Samara National Research University and Samara State Medical University as well as clinic specialists of Samara Regional Oncology Centre tested a new way of skin cancer early diagnostics with the help of original complex of three devices.
› Verified 9 days ago
| Entity Name | Columbia Lutheran Charities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134146939 PECOS PAC ID: 5294643359 Enrollment ID: O20040202000073 |
News Archive
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Using wireless technology may speed patients' postoperative recovery following heart surgery and improve post-discharge outcomes, according to a study in the September 2013 issue of The Annals of Thoracic Surgery.
Researchers at Kanazawa University report in Nature Communications the mechanism making some lung-cancer patients resistant to the drug osimertinib.
According to the American Counsel on Exercise only five percent of dieters are successful in keeping off the weight they lost. In fact, one-third of the weight people initially lost is usually gained back within the first year. People who want to lose weight and keep it off have to not only change their ways, but their way of thinking about food, exercise and lifestyle behaviors.
A team of scholars of Samara National Research University and Samara State Medical University as well as clinic specialists of Samara Regional Oncology Centre tested a new way of skin cancer early diagnostics with the help of original complex of three devices.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Heather Marie Mclean, NP 2111 Exchange St, Astoria, OR 97103-3329 Ph: (503) 325-4321 | Mrs Heather Marie Mclean, NP 2095 Exchange St Ste 301, Astoria, OR 97103-3400 Ph: (503) 338-4087 |
News Archive
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Using wireless technology may speed patients' postoperative recovery following heart surgery and improve post-discharge outcomes, according to a study in the September 2013 issue of The Annals of Thoracic Surgery.
Researchers at Kanazawa University report in Nature Communications the mechanism making some lung-cancer patients resistant to the drug osimertinib.
According to the American Counsel on Exercise only five percent of dieters are successful in keeping off the weight they lost. In fact, one-third of the weight people initially lost is usually gained back within the first year. People who want to lose weight and keep it off have to not only change their ways, but their way of thinking about food, exercise and lifestyle behaviors.
A team of scholars of Samara National Research University and Samara State Medical University as well as clinic specialists of Samara Regional Oncology Centre tested a new way of skin cancer early diagnostics with the help of original complex of three devices.
› Verified 9 days ago
Mr. Terry Dean Hollowell, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2265 Exchange St, Astoria, OR 97103 Phone: 503-338-4050 Fax: 503-338-4051 | |
Amy Katheryn Grace, F.N.P Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2111 Exchange St, Astoria, OR 97103 Phone: 503-325-4321 | |
Brenda Mcnaughton, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2158 Exchange St, Suite 304, Astoria, OR 97103 Phone: 503-325-8315 | |
Ms. Patricia Jean Danforth, CANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2055 Exchange Street, Suite 210, Astoria, OR 97103 Phone: 503-325-3935 Fax: 503-325-3938 | |
Ms. Susan L Skinner, CNM CFNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 595 18th St, Astoria, OR 97103 Phone: 503-325-9131 Fax: 503-325-8797 | |
Christie Marie Rivelli, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2158 Exchange St, Suite 304, Astoria, OR 97103 Phone: 503-325-8315 Fax: 503-325-8602 | |
Erica M Fabiano, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2265 Exchange St, Astoria, OR 97103 Phone: 503-338-4075 Fax: 503-338-4076 |